Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 02 2020
11 02 2020
Historique:
received:
06
08
2019
accepted:
22
01
2020
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
30
3
2021
Statut:
epublish
Résumé
Computed tomography (CT) assessment of the cross-sectional area of the erector spinae muscles (ESM
Identifiants
pubmed: 32047177
doi: 10.1038/s41598-020-59100-5
pii: 10.1038/s41598-020-59100-5
pmc: PMC7012911
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2312Références
Raghu, G. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788–824 (2011).
doi: 10.1164/rccm.2009-040GL
Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 378, 1811–1823 (2018).
doi: 10.1056/NEJMra1705751
Ley, B. et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 156, 684–691 (2012).
doi: 10.7326/0003-4819-156-10-201205150-00004
Natsuizaka, M. et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am. J. Respir. Crit. Care Med. 190, 773–779 (2014).
doi: 10.1164/rccm.201403-0566OC
Sumikawa, H. et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 177, 433–439 (2008).
doi: 10.1164/rccm.200611-1696OC
Enomoto, N. et al. Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir. Med. 107, 1608–1616 (2013).
doi: 10.1016/j.rmed.2013.08.008
Harada, T., Watanabe, K., Nabeshima, K., Hamasaki, M. & Iwasaki, H. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology. 18, 278–283 (2013).
doi: 10.1111/j.1440-1843.2012.02272.x
Tajiri, M. et al. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis. Respir. Investig. 53, 73–81 (2015).
doi: 10.1016/j.resinv.2014.12.003
Song, J. W. et al. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. Chest. 143, 1422–1429 (2013).
doi: 10.1378/chest.11-2735
Furukawa, T. et al. The St. George’s Respiratory Questionnaire as a prognostic factor in IPF. Respir. Res. 18, 18 (2017).
doi: 10.1186/s12931-017-0503-3
Oda, K. et al. High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis. Respir Res. 15, 10 (2014).
doi: 10.1186/1465-9921-15-10
Ohkubo, H. et al. A volumetric computed tomography analysis of the normal lung in idiopathic pulmonary fibrosis: The relationship with the survival. Intern. Med. 57, 929–937 (2018).
doi: 10.2169/internalmedicine.9508-17
Ohkubo, H., Nakagawa, H. & Niimi, A. Computer-based quantitative computed tomography image analysis in idiopathic pulmonary fibrosis: A mini review. Respir Investig. 56, 5–13 (2018).
doi: 10.1016/j.resinv.2017.10.003
Teramachi, R. et al. Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction. Respirology. 22, 986–990 (2017).
doi: 10.1111/resp.12986
Zappala, C. J. et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur. Respir. J. 35, 830–836 (2010).
doi: 10.1183/09031936.00155108
Paterniti, M. O. et al. Acute exacerbation and decline in forced vital capacity are associated with increased mortality in idiopathic pulmonary fibrosis. Ann. Am. Thorac. Soc. 9, 1395–1402 (2017).
doi: 10.1513/AnnalsATS.201606-458OC
Evans, W. J. et al. Cachexia: a new definition. Clin. Nutr. 27, 793–799 (2008).
doi: 10.1016/j.clnu.2008.06.013
Morley, J. E., Thomas, D. R. & Wilson, M. M. Cachexia: pathophysiology and clinical relevance. Am. J. Clin. Nutr. 83, 735–743 (2006).
doi: 10.1093/ajcn/83.4.735
Durham, W. J., Dillon, E. L. & Sheffield-Moore, M. Inflammatory burden and amino acid metabolism cancer cachexia. Curr. Opin. Clin. Nutr. Metab. Care. 12, 72–77 (2009).
doi: 10.1097/MCO.0b013e32831cef61
Cruz-Jentoft, A. J. et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in older people. Age Aging. 39, 412–423 (2010).
doi: 10.1093/ageing/afq034
Tanimura, K. et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Novel chest computed tomography-derived index for prognosis. Ann. Am. Thorac. Soc. 13, 334–341 (2016).
doi: 10.1513/AnnalsATS.201507-446OC
Suzuki, Y. et al. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci. Rep. 8, 14074 (2018).
doi: 10.1038/s41598-018-32478-z
Miller, J. A. et al. Sarcopenia is a predictor of outcomes after lobectomy. J. Thorac. Dis. 10, 432–440 (2018).
doi: 10.21037/jtd.2017.12.39
Moon, S. W. et al. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients. Respir. Res. 20, 35 (2019).
doi: 10.1186/s12931-019-1001-6
Richeldi, L. et al. INPULSIS Trial Investigators: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071–2082 (2014).
doi: 10.1056/NEJMoa1402584
King, T. E. Jr. et al. ASCEND Study Group: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2083–2092 (2014).
doi: 10.1056/NEJMoa1402582
Lederer, D. J. et al. Sensitivity Analyzes of the change in FVC in a Phase 3 Trial of Pirfenidone for idiopathic pulmonary fibrosis. Chest. 148, 196–201 (2018).
doi: 10.1378/chest.14-2817
du Bois, R. M. et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 184, 1382–1389 (2011).
doi: 10.1164/rccm.201105-0840OC
Kinsey, C. M. et al. Lower pectoralis muscle area is associated with worse overall survival in non-small cell lung cancer. Cancer Epidemiol. Biomarkers Prev. 26, 38–43 (2017).
doi: 10.1158/1055-9965.EPI-15-1067
McDonald, M. L. et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann. Am. Thorac. Soc. 11, 326–334 (2014).
doi: 10.1513/AnnalsATS.201307-229OC
Boutin, R. D., Yao, L., Canter, R. J. & Lenchik, L. Sarcopenia: Current concepts and imaging implications. AJR Am. J. Roentgenol. 205, W255–266 (2015).
doi: 10.2214/AJR.15.14635
Canvasser, L. D. et al. Paraspinous muscle as a predictor of surgical outcome. J. Surg. Res. 192, 76–81 (2014).
doi: 10.1016/j.jss.2014.05.057
Asakura, T. et al. Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease. Respir. Med. 145, 66–72 (2018).
doi: 10.1016/j.rmed.2018.10.023
Minegishi, Y. et al. Smaller erector spinae muscle size is associated with inability to recover activities of daily living after pneumonia treatment. Respir. Investig. 57, 191–197 (2019).
doi: 10.1016/j.resinv.2018.11.002
Laszlo, G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 61, 744–746 (2006).
doi: 10.1136/thx.2006.061648
Macintyre, N. et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 26, 720–735 (2005).
doi: 10.1183/09031936.05.00034905
Sasaki, E., Nakamura, M. & Kida, K. [Reference values for spirogram and blood gas analysis in Japanese non-smoking healthy adults] [in Japanese]. Nihon Kokyuki Gakkai Zassi 39, S1–S17 (2001).
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 166, 111–117 (2002).
doi: 10.1164/ajrccm.166.1.at1102
Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 2173, 676–82 (2011).
doi: 10.1093/aje/kwq433